latest news releases from the newsroom
SCA Invests for Increased Competitiveness
STOCKHOLM, Sweden, Dec. 19, 2002 (PRIMEZONE) -- SCA is carrying out investments to increase competitiveness in the Swedish sawmill operations and German packaging operations.
Akzo Nobel and Organon Considering Next Moves Following Adverse Summary Judgement Ruling in Remeron Lawsuit Against Generics
ARNHEM, The Netherlands and WEST ORANGE, N.J., Dec. 19, 2002 (PRIMEZONE) -- Akzo Nobel (Nasdaq:AKZOY) and Organon Inc. confirm that the U.S. Federal District Court in Newark, NJ, has granted summary judgement on non-infringement in favor of Teva Pharmaceuticals USA, Inc. and Mylan Pharmaceutical Inc. in the patent infringement lawsuit concerning Remeron(R) tablets. Akzo Nobel and Organon are studying the court's ruling to determine their next course of action. The lawsuit against Teva and Mylan alleges infringement of a patent covering the use of the antidepressant Remeron (mirtazapine) in combination with one or more SSRIs (selective serotonin reuptake inhibitors) for the treatment of depression.
Hoffman & Edelson LLC
Hoffman & Edelson, LLC Announces February 3, 2003 Filing Deadline for Lead Plaintiff in Class Action Lawsuit Against Annuity and Life Re (Holdings), Ltd. -- ANR
DOYLESTOWN, Pa., Dec. 19, 2002 (PRIMEZONE) -- Hoffman & Edelson, LLC, plaintiffs' counsel in the first filed class action complaint in the United States District Court, District of Connecticut on behalf of purchasers of the securities of Annuity and Life Re (Holdings), Ltd. ("Annuity and Life" or the "Company") (NYSE:ANR) during the period from February 12, 2001 through November 19, 2002, inclusive (the "Class Period") announces a February 3, 2003 filing deadline for appointment of lead plaintiff in the class action lawsuit. The lawsuit is brought against defendants Annuity and Life, Frederick S. Hammer, Lawrence S. Doyle and John F. Burke.
Chitwood & Harley
Chitwood & Harley Reminds Investors of December 31 Lead Plaintiff Filing Deadline and of Availability of FBI Affidavit in Securities Fraud Suit Against Tenet Healthcare Corporation; FBI Affidavit Available on our Website -- THC
ATLANTA, Dec. 18, 2002 (PRIMEZONE) -- Chitwood & Harley previously announced the filing on November 4th of the initial class action suit filed in the United States District Court for the Central District of California against Tenet Healthcare Corporation on behalf of all persons who purchased or otherwise acquired the securities of Tenet Healthcare Corporation ("Tenet" or the "Company") (NYSE:THC) from October 3, 2001 through October 31, 2002, inclusive (the "Class Period"). If you are interested in serving as a lead plaintiff in this action, the deadline to file papers seeking your appointment is December 31, 2002. There are certain legal requirements to serve as lead plaintiff, which we would be happy to discuss with you. Any member of the purported class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. If you wish to discuss this action or have any questions concerning this notice or your rights with respect to this matter, you may contact Jennifer Morris at 1-888-873-3999 (toll-free) or by e-mail at firstname.lastname@example.org.
Chitwood & Harley
6 Days Left to File Lead Plaintiff Papers, Chitwood & Harley Reminds Investors of Cigna Corp. in Securities Fraud Suit -- CI
ATLANTA, Dec. 18, 2002 (PRIMEZONE) -- Chitwood & Harley reminds investors that December 24, 2002 is the deadline by which class members must file papers requesting appointment as a lead plaintiff, if interested in serving in this role, in the securities class action law suit against CIGNA Corp. ("CIGNA" or the "Company") (NYSE:CI). You are a class member if you purchased or otherwise acquired the securities of CIGNA between May 2, 2001 through October 24, 2002, inclusive (the "Class Period"). The lawsuit, previously filed by Chitwood & Harley in the Eastern District of Pennsylvania, alleges that CIGNA and other defendants, including H. Edward Hanway, Chief Executive Officer, President and Chairman of the Board; James G. Stewart, Chief Financial Officer and Executive Vice President; and James A. Sears, Chief Accounting Officer, violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, by issuing a series of materially false and misleading statements to the market. On November 1, 2002 CIGNA disclosed that the Securities and Exchange Commission ("SEC") had launched an inquiry into the company. A copy of the complaint can be viewed at www.classlaw.com.
Interland Event to be Broadcast by Vcall over the Internet
RICHMOND, Va., Dec. 18, 2002 (PRIMEZONE) -- Interland, Inc. (Nasdaq:INLD) will broadcast its quarterly results event on Thursday, 12/19/2002, at 4:30 PM Eastern, Vcall, a Service of WILink, announced today. This event webcast can be accessed at http://www.vcall.com/EventPage.asp?ID=82907